Innovotech (CVE:IOT) Director Craig Milne Acquires 135,000 Shares of Stock

Innovotech Inc. (CVE:IOT) Director Craig Milne purchased 135,000 shares of the company’s stock in a transaction dated Friday, July 3rd. The shares were acquired at an average cost of C$0.08 per share, for a total transaction of C$10,800.00. Following the transaction, the director owned 1,733,615 shares of the company’s stock, valued at C$138,689.20. This trade represents a 8.44% increase in their ownership of the stock.

Innovotech Price Performance

Shares of IOT opened at C$0.09 on Wednesday. The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.81 and a current ratio of 2.63. The stock has a 50 day simple moving average of C$0.13 and a 200 day simple moving average of C$0.19. Innovotech Inc. has a 52-week low of C$0.08 and a 52-week high of C$0.34. The firm has a market capitalization of C$4.90 million, a PE ratio of -13.22 and a beta of 2.64.

Innovotech Company Profile

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.